Vitamin D levels appear to play role in COVID-19 mortality rates
Vitamin D levels appear to play role in COVID-19 mortality rates Patients with severe deficiency are twice as likely to experience major complications After studying global data from
Researchers identify cells likely targeted by COVID-19 virus
Photo: CDC Researchers identify cells likely targeted by COVID-19 virus Study finds specific cells in the lungs, nasal passages, and intestines that are more susceptible to infection
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the NYC Area
Photo: CDC Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area Key Points Question What are the characteristics, clinical presentation,
COVID-19 and African Americans
Photo: NCI COVID-19 and African Americans Clyde W. Yancy, MD, MSc1 Much has been published in leading medical journals about the phenomenon of severe acute respiratory syndrome coronavirus 2
Loss of smell and taste validated as COVID-19 symptoms
Photo: NCI Loss of smell and taste validated as COVID-19 symptoms in patients with high recovery rate Study suggests clinicians should include sensory impairment as standard screening
COVID-19 drug lead treatments identified
Photo: CDC COVID-19 drug lead treatments identified An international team of researchers has tested more than 10,000 compounds to identify six drug candidates that may help treat
What type of cells does the novel coronavirus attack?
Photo: CDC What type of cells does the novel coronavirus attack? Scientists from the Berlin Institute of Health (BIH), Charité -- Universitätsmedizin Berlin and the Thorax Clinic
NIH clinical trial of hydroxychloroquine, a potential therapy for COVID-19, begins
Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (purple), isolated from a patient sample. Image captured and color-enhanced at the NIAID Integrated Research
Blood test detects dozens of cancer types, often before symptoms emerge
Photo courtesy of: NCI Blood test detects dozens of cancer types, often before symptoms emerge A novel blood test accurately detected more than 50 types of cancer
Latest from the NCI
- Study Offers Insights on Health Problems among AYA Cancer Survivors
A study found that the risk of developing any of 26 chronic health problems was about 50% higher among cancer survivors who were diagnosed as adolescents and young adults, compared with their peers who did not have cancer. Read more » - Scientists Focus on Fusion Proteins in Childhood Cancers
Fusion proteins drive the development of many cancers in children, yet little is known about their biology. NCI’s Fusion Oncoproteins in Childhood Cancers Consortium brings together experts from varied disciplines to investigate these cancers. Read more » - How Does Ovarian Cancer Form? A New Study Points to MicroRNA
A microRNA—a molecule made by cells to turn genes on and off—called miR-181a may help high-grade serous ovarian cancer form, a study has found. The scientists think the microRNA could potentially help doctors detect ovarian cancer earlier. Read more » - How CRISPR Is Changing Cancer Research and Treatment
The gene-editing tool CRISPR is changing the way scientists study cancer, and may change how cancer is treated. This in-depth blog post describes how this revolutionary technology is being used to better understand cancer and create new treatments. Read more » - Liquid Biopsy Detects Brain Cancer and Early-Stage Kidney Cancer
Results from two studies show that a liquid biopsy that analyzes DNA in blood accurately detected kidney cancer at early and more advanced stages and identified and classified different types of brain tumors. Read more » - Rediscovered Drugs Hit Leukemia from Two Different Angles
Two rediscovered drugs, bisantrene and brequinar, slowed the growth of acute myeloid leukemia in studies of mice. The drugs blocked the activity of a protein called FTO, killing cancer stem cells and helping the immune system attack the cancer. Read more » - Ovarian Cancer Studies Aim to Reduce Racial Disparities, Improve Outcomes
Three recently launched NCI-supported studies could help researchers better understand the causes of racial/ethnic disparities in ovarian cancer. The ultimate goal is to eliminate disparities and improve survival for all women with the disease. Read more » - CCDI Activities Enhance NCI’s Childhood and AYA Cancer Research
Since launching the Childhood Cancer Data Initiative, NCI has undertaken a range of research activities to support this important effort. In this Cancer Currents post, NCI Director Dr. Norman Sharpless provides an update on these efforts. Read more »
CHANGE A LIFE TODAY
As long as cancer persists, none of us can truly rest. It doesn’t take much to change a life, Get in touch today and start making the difference.